Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A DORIA

Showing results (241-250 of 667) with videos related to

Pageof 67
Sort By:
Structure (London, England : 1993)|August 2, 2016
Somatic Hypermutation-Induced Changes in the Structure and Dynamics of HIV-1 Broadly Neutralizing AntibodiesThaddeus M Davenport, Jason Gorman, M Gordon Joyce, et al.
Nature Communications|June 24, 2024
RAIN: machine learning-based identification for HIV-1 bNAbsMathilde Foglierini, Pauline Nortier, Rachel Schelling, et al.
Annals of the Rheumatic Diseases|May 5, 2010
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?H Amital, Z Szekanecz, G Szücs, et al.
Journal of Virology|August 17, 2005
Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelopeN A Doria-Rose, G H Learn, A G Rodrigo, et al.
Journal of Virology|October 17, 2008
Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodiesNicole A Doria-Rose, Rachel M Klein, Maura M Manion, et al.
Infectious Diseases (London, England)|October 16, 2018
Limited anti-HIV neutralizing antibody breadth and potency before and after HIV superinfection in Danish men who have sex with menAndrew D Redd, Marie Helleberg, Matthew Sievers, et al.
Journal of Virology|May 25, 2012
A short segment of the HIV-1 gp120 V1/V2 region is a major determinant of resistance to V1/V2 neutralizing antibodiesNicole A Doria-Rose, Ivelin Georgiev, Sijy O'Dell, et al.
Nature Communications|November 10, 2021
Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfacesMyungjin Lee, Anita Changela, Jason Gorman, et al.
Plos Pathogens|April 23, 2026
Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potentialBette Korber, Michael S Seaman, Nonhlanhla N Mkhize, et al.
Journal of Virology|July 12, 2013
Residue-level prediction of HIV-1 antibody epitopes based on neutralization of diverse viral strainsGwo-Yu Chuang, Priyamvada Acharya, Stephen D Schmidt, et al.
Pageof 67

Showing results (241-250 of 667) with videos related to

Sort By:
Pageof 67
Structure (London, England : 1993)|August 2, 2016
Somatic Hypermutation-Induced Changes in the Structure and Dynamics of HIV-1 Broadly Neutralizing AntibodiesThaddeus M Davenport, Jason Gorman, M Gordon Joyce, et al.
Nature Communications|June 24, 2024
RAIN: machine learning-based identification for HIV-1 bNAbsMathilde Foglierini, Pauline Nortier, Rachel Schelling, et al.
Annals of the Rheumatic Diseases|May 5, 2010
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?H Amital, Z Szekanecz, G Szücs, et al.
Journal of Virology|August 17, 2005
Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelopeN A Doria-Rose, G H Learn, A G Rodrigo, et al.
Journal of Virology|October 17, 2008
Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodiesNicole A Doria-Rose, Rachel M Klein, Maura M Manion, et al.
Infectious Diseases (London, England)|October 16, 2018
Limited anti-HIV neutralizing antibody breadth and potency before and after HIV superinfection in Danish men who have sex with menAndrew D Redd, Marie Helleberg, Matthew Sievers, et al.
Journal of Virology|May 25, 2012
A short segment of the HIV-1 gp120 V1/V2 region is a major determinant of resistance to V1/V2 neutralizing antibodiesNicole A Doria-Rose, Ivelin Georgiev, Sijy O'Dell, et al.
Nature Communications|November 10, 2021
Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfacesMyungjin Lee, Anita Changela, Jason Gorman, et al.
Plos Pathogens|April 23, 2026
Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potentialBette Korber, Michael S Seaman, Nonhlanhla N Mkhize, et al.
Journal of Virology|July 12, 2013
Residue-level prediction of HIV-1 antibody epitopes based on neutralization of diverse viral strainsGwo-Yu Chuang, Priyamvada Acharya, Stephen D Schmidt, et al.
Pageof 67